GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasRobbie G. Majzner, Michelle Monje|Nature|2022Cited by 769
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S. Grasso, Michelle Monje, Yujie Tang et al.|Nature Medicine|2015Cited by 711
Distinguishing features of long COVID identified through immune profilingJon Klein, Akiko Iwasaki, Saad B. Omer et al.|Nature|2023Cited by 676
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulationAnthony Fernández-Castañeda, Michelle Monje, Peiwen Lu et al.|Cell|2022Cited by 512
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSamuel Cheshier, Siddhartha S. Mitra, Abdullah H. Feroze et al.|Science Translational Medicine|2017Cited by 427